BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7299131)

  • 1. Cellular dissemination of priming for a mucosal immune response to cholera toxin in rats.
    Pierce NF; Cray WC
    J Immunol; 1981 Dec; 127(6):2461-4. PubMed ID: 7299131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats.
    Pierce NF; Cray WC
    J Immunol; 1982 Mar; 128(3):1311-5. PubMed ID: 6173431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response.
    Koster FT; Pierce NF
    J Immunol; 1983 Jul; 131(1):115-9. PubMed ID: 6190901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats.
    Pierce NF; Koster FT
    J Immunol; 1980 Jan; 124(1):307-11. PubMed ID: 6965294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunization.
    Vajdy M; Lycke N
    Immunology; 1995 Nov; 86(3):336-42. PubMed ID: 8550068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival immunity: compared effects of ocular or intestinal immunization in rats.
    Pu Z; Pierce NF; Silverstein AM; Prendergast RA
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1411-2. PubMed ID: 6618801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of optimal mucosal antibody responses: effects of age, immunization route(s), and dosing schedule in rats.
    Pierce NF
    Infect Immun; 1984 Jan; 43(1):341-6. PubMed ID: 6606625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
    Lycke N
    Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8(+) T cell population in different tissues.
    Qimron U; Paul L; Bar-Haim E; Bloushtain N; Eisenbach L; Staats HF; Porgador A
    Vaccine; 2004 Mar; 22(11-12):1390-4. PubMed ID: 15063561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immune response to cholera toxin--cellular basis of memory and adjuvant action.
    Lycke N; Holmgren J
    Monogr Allergy; 1988; 24():274-81. PubMed ID: 3258956
    [No Abstract]   [Full Text] [Related]  

  • 12. A two-codon mutant of cholera toxin lacking ADP-ribosylating activity functions as an effective adjuvant for eliciting mucosal and systemic cellular immune responses to peptide antigens.
    Lomada D; Gambhira R; Nehete PN; Guhad FA; Chopra AK; Peterson JW; Sastry KJ
    Vaccine; 2004 Dec; 23(4):555-65. PubMed ID: 15530705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of mucosal immunity in humans: relevance to vaccine development.
    Czerkinsky C; Holmgren J
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():37-44. PubMed ID: 7950860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
    Matoba N; Geyer BC; Kilbourne J; Alfsen A; Bomsel M; Mor TS
    Vaccine; 2006 Jun; 24(23):5047-55. PubMed ID: 16621185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives in vaccine development: mucosal immunity to infections.
    McGhee JR; Kiyono H
    Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E; Westrich GM; Viney JL
    J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The properities of lymphocytes which carry immunologic memory of phiX 174.
    McGregor DD; Mackaness GB
    J Immunol; 1975 Jan; 114(1 Pt 2):336-42. PubMed ID: 1117131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protein deprivation on immunoregulatory cells in the rat mucosal immune response.
    Koster F; Pierce NF
    Clin Exp Immunol; 1985 Apr; 60(1):217-24. PubMed ID: 4006300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mucosa of the male genital tract; part of the common mucosal secretory immune system?
    Fritz FJ; Westermann J; Pabst R
    Eur J Immunol; 1989 Mar; 19(3):475-9. PubMed ID: 2785042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A matter of timing: unsynchronized antigen expression and antigen presentation diminish secondary T cell responses.
    Elnekave M; Bivas-Benita M; Gillard GO; Sircar P; Hovav AH
    J Immunol; 2009 Jul; 183(2):1013-21. PubMed ID: 19561108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.